Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.

The Janus Kinase 2 (JAK2) plays essential roles in transmitting signals from multiple cytokine receptors, and constitutive activation of JAK2 results in hematopoietic disorders and oncogenesis. JAK2 kinase activity is negatively regulated by its pseudokinase domain (JH2), where the gain-of-function...

Full description

Bibliographic Details
Main Authors: Xiaobo Wan, Yue Ma, Christopher L McClendon, Lily Jun-shen Huang, Niu Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-04-01
Series:PLoS Computational Biology
Online Access:http://europepmc.org/articles/PMC3616975?pdf=render
id doaj-f1e01e537402430cbfda52ce21bb4408
record_format Article
spelling doaj-f1e01e537402430cbfda52ce21bb44082020-11-25T01:18:25ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582013-04-0194e100302210.1371/journal.pcbi.1003022Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.Xiaobo WanYue MaChristopher L McClendonLily Jun-shen HuangNiu HuangThe Janus Kinase 2 (JAK2) plays essential roles in transmitting signals from multiple cytokine receptors, and constitutive activation of JAK2 results in hematopoietic disorders and oncogenesis. JAK2 kinase activity is negatively regulated by its pseudokinase domain (JH2), where the gain-of-function mutation V617F that causes myeloproliferative neoplasms resides. In the absence of a crystal structure of full-length JAK2, how JH2 inhibits the kinase domain (JH1), and how V617F hyperactivates JAK2 remain elusive. We modeled the JAK2 JH1-JH2 complex structure using a novel informatics-guided protein-protein docking strategy. A detailed JAK2 JH2-mediated auto-inhibition mechanism is proposed, where JH2 traps the activation loop of JH1 in an inactive conformation and blocks the movement of kinase αC helix through critical hydrophobic contacts and extensive electrostatic interactions. These stabilizing interactions are less favorable in JAK2-V617F. Notably, several predicted binding interfacial residues in JH2 were confirmed to hyperactivate JAK2 kinase activity in site-directed mutagenesis and BaF3/EpoR cell transformation studies. Although there may exist other JH2-mediated mechanisms to control JH1, our JH1-JH2 structural model represents a verifiable working hypothesis for further experimental studies to elucidate the role of JH2 in regulating JAK2 in both normal and pathological settings.http://europepmc.org/articles/PMC3616975?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Xiaobo Wan
Yue Ma
Christopher L McClendon
Lily Jun-shen Huang
Niu Huang
spellingShingle Xiaobo Wan
Yue Ma
Christopher L McClendon
Lily Jun-shen Huang
Niu Huang
Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
PLoS Computational Biology
author_facet Xiaobo Wan
Yue Ma
Christopher L McClendon
Lily Jun-shen Huang
Niu Huang
author_sort Xiaobo Wan
title Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
title_short Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
title_full Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
title_fullStr Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
title_full_unstemmed Ab initio modeling and experimental assessment of Janus Kinase 2 (JAK2) kinase-pseudokinase complex structure.
title_sort ab initio modeling and experimental assessment of janus kinase 2 (jak2) kinase-pseudokinase complex structure.
publisher Public Library of Science (PLoS)
series PLoS Computational Biology
issn 1553-734X
1553-7358
publishDate 2013-04-01
description The Janus Kinase 2 (JAK2) plays essential roles in transmitting signals from multiple cytokine receptors, and constitutive activation of JAK2 results in hematopoietic disorders and oncogenesis. JAK2 kinase activity is negatively regulated by its pseudokinase domain (JH2), where the gain-of-function mutation V617F that causes myeloproliferative neoplasms resides. In the absence of a crystal structure of full-length JAK2, how JH2 inhibits the kinase domain (JH1), and how V617F hyperactivates JAK2 remain elusive. We modeled the JAK2 JH1-JH2 complex structure using a novel informatics-guided protein-protein docking strategy. A detailed JAK2 JH2-mediated auto-inhibition mechanism is proposed, where JH2 traps the activation loop of JH1 in an inactive conformation and blocks the movement of kinase αC helix through critical hydrophobic contacts and extensive electrostatic interactions. These stabilizing interactions are less favorable in JAK2-V617F. Notably, several predicted binding interfacial residues in JH2 were confirmed to hyperactivate JAK2 kinase activity in site-directed mutagenesis and BaF3/EpoR cell transformation studies. Although there may exist other JH2-mediated mechanisms to control JH1, our JH1-JH2 structural model represents a verifiable working hypothesis for further experimental studies to elucidate the role of JH2 in regulating JAK2 in both normal and pathological settings.
url http://europepmc.org/articles/PMC3616975?pdf=render
work_keys_str_mv AT xiaobowan abinitiomodelingandexperimentalassessmentofjanuskinase2jak2kinasepseudokinasecomplexstructure
AT yuema abinitiomodelingandexperimentalassessmentofjanuskinase2jak2kinasepseudokinasecomplexstructure
AT christopherlmcclendon abinitiomodelingandexperimentalassessmentofjanuskinase2jak2kinasepseudokinasecomplexstructure
AT lilyjunshenhuang abinitiomodelingandexperimentalassessmentofjanuskinase2jak2kinasepseudokinasecomplexstructure
AT niuhuang abinitiomodelingandexperimentalassessmentofjanuskinase2jak2kinasepseudokinasecomplexstructure
_version_ 1725142617659801600